-+ 0.00%
-+ 0.00%
-+ 0.00%

VAXCYTE, INC.: TO REPORT RESULTS FROM OPUS-2 AND OPUS-3 ADULT PHASE 3 TRIALS IN FIRST HALF OF 2027

Reuters·10/05/2026 10:02:07